Brett Sandercock - 10 Aug 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
10 Aug 2022
Transactions value $
-$457,250
Form type
4
Filing time
12 Aug 2022, 12:11:44 UTC
Previous filing
26 Jul 2022
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144,400 +2,500 +2.3% $57.76 108,926 10 Aug 2022 Direct F1
transaction RMD ResMed Common Stock Sale -$601,650 -2,500 -2.3% $240.66 106,426 10 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2,500 -100% $0* 0 10 Aug 2022 ResMed Common Stock 2,500 $57.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.